{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:35:34Z","timestamp":1775230534988,"version":"3.50.1"},"reference-count":170,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Biology &amp; Therapy"],"published-print":{"date-parts":[[2011,8,15]]},"DOI":"10.4161\/cbt.12.4.16430","type":"journal-article","created":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T11:09:36Z","timestamp":1313406576000},"page":"260-269","source":"Crossref","is-referenced-by-count":71,"title":["Src family kinases and paclitaxel sensitivity"],"prefix":"10.1080","volume":"12","author":[{"given":"Xiao-Feng","family":"Le","sequence":"first","affiliation":[{"name":"University of Texas MD Anderson Cancer Center, Houston, TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Bast, Jr.","sequence":"additional","affiliation":[{"name":"University of Texas MD Anderson Cancer Center, Houston, TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,8,15]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.129"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.13.1.513"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.10.15.1845"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/1357-2725(95)00024-J"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90642-4"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90641-3"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.15.8779"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1719633"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152007784111278"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1708916"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.21.12481"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.03.012"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47102-5"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.04.025"},{"key":"e_1_3_3_16_1","first-page":"3","article-title":"Transmembrane signaling by G protein-coupled receptors","volume":"332","author":"Luttrell LM","year":"2006","unstructured":"Luttrell LM. Transmembrane signaling by G protein-coupled receptors. Methods Mol Biol 2006; 332:3 - 49","journal-title":"Methods Mol Biol"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.03.026"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2007.08.012"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0009"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2010.08.014"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.2174\/187153008786848295"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.10328"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.7.2008"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.09.001"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi012097n"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25426"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.07.031"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/269346a0"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(78)90024-7"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023772912750"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1139\/o03-077"},{"key":"e_1_3_3_32_1","first-page":"171","article-title":"Activity of pp60c-src in 60 different cell lines derived from human tumors","volume":"14","author":"Budde RJ","year":"1994","unstructured":"Budde RJ, Ke S, Levin VA. Activity of pp60c-src in 60 different cell lines derived from human tumors. Cancer Biochem Biophys 1994; 14:171 - 175","journal-title":"Cancer Biochem Biophys"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.8.1.23"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.14.1.735-743.1994"},{"key":"e_1_3_3_35_1","first-page":"1696","article-title":"Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas","volume":"43","author":"Jacobs C","year":"1983","unstructured":"Jacobs C, Rubsamen H. Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas. Cancer Res 1983; 43:1696 - 1702","journal-title":"Cancer Res"},{"key":"e_1_3_3_36_1","first-page":"4773","article-title":"Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product","volume":"52","author":"Ottenhoff-Kalff AE","year":"1992","unstructured":"Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res 1992; 52:4773 - 4778","journal-title":"Cancer Res"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605829"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603444"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9214"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2353"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.12.6.757"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn291"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2002.6851"},{"key":"e_1_3_3_45_1","first-page":"2164","article-title":"Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model","volume":"5","author":"Wiener JR","year":"1999","unstructured":"Wiener JR, Nakano K, Kruzelock RP, Bucana CD, Bast RC Jr, Gallick GE. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Clin Cancer Res 1999; 5:2164 - 2170","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309131200"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501406200"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23579"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2008.40.6.607"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.20160"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200408130"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M611539200"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5698"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0807158106"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M006498200"},{"key":"e_1_3_3_56_1","first-page":"683","article-title":"[The detection of the c-src protein gene product in human lung tumors]","volume":"37","author":"Mazurenko NN","year":"1991","unstructured":"Mazurenko NN, Kogan EA, Zborovskaia IB, Sukhova NM, Kiselev FL. [The detection of the c-src protein gene product in human lung tumors]. Vopr Onkol 1991; 37:683 - 690","journal-title":"Vopr Onkol"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(03)00276-4"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.060706"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0757"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-005-7768-5"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2006.n.020"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4620"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn048"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-09-0003"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2010.n.030"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2008.03.008"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0504"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1998.tb01931.x"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5226"},{"key":"e_1_3_3_70_1","article-title":"Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma","author":"Brooks HD","year":"2010","unstructured":"Brooks HD, Glisson BS, Bekele BN, Ginsberg LE, El-Naggar A, Culotta KS, et al. Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma. Cancer 2010; In press","journal-title":"Cancer"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)01154-7"},{"key":"e_1_3_3_72_1","first-page":"55","article-title":"Taxol: mechanisms of action and resistance","author":"Horwitz SB","year":"1993","unstructured":"Horwitz SB, Cohen D, Rao S, Ringel I, Shen HJ, Yang CP. Taxol: mechanisms of action and resistance. J Natl Cancer Inst Monogr 1993; 55 - 61","journal-title":"J Natl Cancer Inst Monogr"},{"key":"e_1_3_3_73_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/j.1875-9114.1997.tb03813.x","article-title":"Clinical overview of the taxanes","volume":"17","author":"Goldspiel BR","year":"1997","unstructured":"Goldspiel BR. Clinical overview of the taxanes. Pharmacotherapy 1997; 17:110 - 125","journal-title":"Pharmacotherapy"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/277665a0"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.3.1561"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/5.suppl_5.3"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207528"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.228"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.12.073"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0549"},{"key":"e_1_3_3_81_1","first-page":"1843","article-title":"The microtubule-affecting drug paclitaxel has antiangiogenic activity","volume":"2","author":"Belotti D","year":"1996","unstructured":"Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, et al. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 1996; 2:1843 - 1849","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm172"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2803"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-416-6_4"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2003.11.053"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059284"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-2088"},{"key":"e_1_3_3_88_1","first-page":"393","article-title":"Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines","volume":"30","author":"Naramoto H","year":"2007","unstructured":"Naramoto H, Uematsu T, Uchihashi T, Doto R, Matsuura T, Usui Y, et al. Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines. Int J Oncol 2007; 30:393 - 401","journal-title":"Int J Oncol"},{"key":"e_1_3_3_89_1","first-page":"2119","article-title":"Sabarubicin-(MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF\u03baB) activation: effect of parthenolide on their cytotoxicity","volume":"25","author":"Bellarosa D","year":"2005","unstructured":"Bellarosa D, Binaschi M, Maggi CA, Goso C. Sabarubicin-(MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF\u03baB) activation: effect of parthenolide on their cytotoxicity. Anticancer Res 2005; 25:2119 - 2128","journal-title":"Anticancer Res"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2008.10.001"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206934"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.24.11358"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119642"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0509"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0679"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690507"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.3.1061"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/cm.1026"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201658"},{"key":"e_1_3_3_100_1","first-page":"3537","article-title":"Taxol and antistathmin therapy: a synergistic combination that targets the mitotic spindle","volume":"60","author":"Iancu C","year":"2000","unstructured":"Iancu C, Mistry SJ, Arkin S, Atweh GF. Taxol and antistathmin therapy: a synergistic combination that targets the mitotic spindle. Cancer Res 2000; 60:3537 - 3541","journal-title":"Cancer Res"},{"key":"e_1_3_3_101_1","first-page":"6864","article-title":"Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer","volume":"62","author":"Alli E","year":"2002","unstructured":"Alli E, Bash-Babula J, Yang JM, Hait WN. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 2002; 62:6864 - 6869","journal-title":"Cancer Res"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.11.014"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300957200"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg307"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310947200"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-002-8518-3"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0954"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-43"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209323"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.34.24378"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21573"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408974102"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.6887"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_3_115_1","first-page":"870","article-title":"p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel","volume":"57","author":"Debernardis D","year":"1997","unstructured":"Debernardis D, Sire EG, De Feudis P, Vikhanskaya F, Valenti M, Russo P, et al. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res 1997; 57:870 - 874","journal-title":"Cancer Res"},{"key":"e_1_3_3_116_1","first-page":"313","article-title":"Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer","volume":"34","author":"Tabuchi Y","year":"2009","unstructured":"Tabuchi Y, Matsuoka J, Gunduz M, Imada T, Ono R, Ito M, et al. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. Int J Oncol 2009; 34:313 - 319","journal-title":"Int J Oncol"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.083337"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0791"},{"key":"e_1_3_3_119_1","first-page":"1207","article-title":"Elevated levels of microtubule destabilizing factors in a Taxol-resistant\/dependent A549 cell line with an alpha-tubulin mutation","volume":"63","author":"Martello LA","year":"2003","unstructured":"Martello LA, Verdier-Pinard P, Shen HJ, He L, Torres K, Orr GA, et al. Elevated levels of microtubule destabilizing factors in a Taxol-resistant\/dependent A549 cell line with an alpha-tubulin mutation. Cancer Res 2003; 63:1207 - 1213","journal-title":"Cancer Res"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.27.17118"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.34.23875"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2007.07.022"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10575"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(01)00291-4"},{"key":"e_1_3_3_125_1","first-page":"215","article-title":"Conservation of the class I beta-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancers","volume":"1","author":"Sale S","year":"2002","unstructured":"Sale S, Sung R, Shen P, Yu K, Wang Y, Duran GE, et al. Conservation of the class I beta-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancers. Mol Cancer Ther 2002; 1:215 - 225","journal-title":"Mol Cancer Ther"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0674"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-007-9045-3"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986708786848479"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3096"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2306"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24273"},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.10.4.947"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00007a014"},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1317"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.217.4.2"},{"key":"e_1_3_3_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.11.017"},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.08.012"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1822"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1410"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2081"},{"key":"e_1_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0446"},{"key":"e_1_3_3_142_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M408550200"},{"key":"e_1_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605381"},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5023"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.12.018"},{"key":"e_1_3_3_146_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0669"},{"key":"e_1_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601909358324"},{"key":"e_1_3_3_148_1","first-page":"3917","article-title":"The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells","volume":"118","author":"Lu Z","year":"2008","unstructured":"Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 2008; 118:3917 - 3929","journal-title":"J Clin Invest"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-22"},{"key":"e_1_3_3_150_1","first-page":"557","article-title":"Effect of autophagy on paclitaxel-induced CaSki cell death","volume":"35","author":"Sun Y","year":"2010","unstructured":"Sun Y, Jin L, Liu J, Lin S, Yang Y, Sui Y, et al. Effect of autophagy on paclitaxel-induced CaSki cell death. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010; 35:557 - 565","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"e_1_3_3_151_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-135"},{"key":"e_1_3_3_152_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.8.11299"},{"key":"e_1_3_3_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.08.027"},{"key":"e_1_3_3_154_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001887200"},{"key":"e_1_3_3_155_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411380200"},{"key":"e_1_3_3_156_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.23.7212"},{"key":"e_1_3_3_157_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318549"},{"key":"e_1_3_3_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209685"},{"key":"e_1_3_3_159_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.9.3.10635"},{"key":"e_1_3_3_160_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0025"},{"key":"e_1_3_3_161_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9463-x"},{"key":"e_1_3_3_162_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3633"},{"key":"e_1_3_3_163_1","first-page":"R255.1","article-title":"Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring","volume":"8","author":"Wang XD","year":"2007","unstructured":"Wang XD, Reeves K, Luo FR, Xu LA, Lee F, Clark E, et al. Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring. Genome Biol 2007; 8:R255.1 - R255.9","journal-title":"Genome Biol"},{"key":"e_1_3_3_164_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0382"},{"key":"e_1_3_3_165_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M608857200"},{"key":"e_1_3_3_166_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4697"},{"key":"e_1_3_3_167_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj414"},{"key":"e_1_3_3_168_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.8.11.8523"},{"key":"e_1_3_3_169_1","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdr018","article-title":"A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer","author":"Fornier MN","year":"2011","unstructured":"Fornier MN, Morris PG, Abbruzzi A, D'Andrea G, Gilewski T, Bromberg J, et al. A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer. Ann Oncol 2011; In press","journal-title":"Ann Oncol"},{"key":"e_1_3_3_170_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903119167"},{"key":"e_1_3_3_171_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.9548"}],"container-title":["Cancer Biology &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/cbt.12.4.16430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:45:56Z","timestamp":1772761556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4161\/cbt.12.4.16430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,15]]},"references-count":170,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8,15]]}},"alternative-id":["10.4161\/cbt.12.4.16430"],"URL":"https:\/\/doi.org\/10.4161\/cbt.12.4.16430","relation":{},"ISSN":["1538-4047","1555-8576"],"issn-type":[{"value":"1538-4047","type":"print"},{"value":"1555-8576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,15]]}}}